Literature DB >> 19522961

The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review.

Sheng-Wen He1, Le-Xin Wang.   

Abstract

The aim of this study was to assess the impact of anemia on the clinical outcomes of chronic heart failure (CHF) by a meta-analysis and systemic review of published literatures. Twenty published English-language articles were selected from Medline, PubMed, and ISI Database. Clinical data were extracted, pooled, and analyzed with a fixed- or random-effects model. A total of 97,699 patients with CHF were identified from the published studies. Meta-analysis of these studies indicated that anemia is associated with a higher risk for death (relative risk [RR], 1.66; P<.0001). In addition, anemic patients had more advanced New York Heart Association class (III or IV; RR, 1.35; P<.0001) and lower left ventricular ejection fraction (weight mean difference, -0.53; P<.0001) than nonanemic patients. Systemic review also revealed that the severity of anemia is closely related to the rate of mortality and hospitalization for heart failure. Anemia is associated with an increased risk of mortality and rate of hospitalization for heart failure. Anemia is an independent risk factor for adverse outcomes in patients with CHF.

Entities:  

Mesh:

Year:  2009        PMID: 19522961     DOI: 10.1111/j.1751-7133.2008.00030.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  16 in total

1.  Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.

Authors:  Michael E Nassif; Jayendrakumar S Patel; Jerrica E Shuster; David S Raymer; Ronald Jackups; Eric Novak; Brian F Gage; Sunil Prasad; Scott C Silvestry; Gregory A Ewald; Shane J LaRue
Journal:  JACC Heart Fail       Date:  2015-02       Impact factor: 12.035

2.  A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction.

Authors:  Arman Altincatal; Robert B Macarthur; Sergio Teruya; Stephen Helmke; Mathew S Maurer
Journal:  Cardiovasc Ther       Date:  2011-08-26       Impact factor: 3.023

Review 3.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 4.  The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.

Authors:  Donald S Silverberg
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

5.  Association between anemia and packed cell transfusion and outcomes of ventricular septal defect and atrioventricular canal repair in children.

Authors:  Zeeshan Khan; Girija Natarajan; Salaam Sallaam; Igor Bondarenko; Henry L Walters; Ralph Delius; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2013-10-24       Impact factor: 1.655

6.  Epoetin alfa in Pediatric Patients With Ventricular Assist Devices: Is It Safe?

Authors:  Kaitlynn Hughes; Audrey Jarosz; David M Peng; Ashley Huebschman
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

7.  Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

Authors:  Philip Green; Benson A Babu; Sergio Teruya; Stephen Helmke; Martin Prince; Mathew S Maurer
Journal:  Congest Heart Fail       Date:  2013-03-20

8.  Adherence to treatment guidelines in the pharmacological management of chronic heart failure in an Australian population.

Authors:  Dao-Kuo Yao; Le-Xin Wang; Shane Curran; Patrick Ball
Journal:  J Geriatr Cardiol       Date:  2011-06       Impact factor: 3.327

Review 9.  Anemia, heart failure and evidence-based clinical management.

Authors:  Camila Alves Pereira; Meliza Goi Roscani; Silméia Garcia Zanati; Beatriz Bojikian Matsubara
Journal:  Arq Bras Cardiol       Date:  2013-07       Impact factor: 2.000

10.  Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.

Authors:  Mara A McAdams-DeMarco; Janet W Maynard; Josef Coresh; Alan N Baer
Journal:  Arthritis Res Ther       Date:  2012-08-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.